Our Scientific Advisors.
EVORÍ is advised by Korean biotech scientists in nanomaterial delivery, cellular longevity, transdermal pharmacology, dermatology, and regulatory science. They shape what we formulate, how we test it, and what we are permitted to claim.
Scientific Governance.
Advisors are not decorative. Each holds a Ph.D. from a top-tier institution and has published in peer-reviewed journals — and each has a defined remit that touches the product before it reaches skin.
The board spans the full chain of a delivery-led anti-aging product: the material science of the spicule itself, the longevity biology of the actives it carries, the transdermal pharmacology that governs how deep they go, the clinical dermatology that verifies safety, and the regulatory science that keeps every claim substantiated. No single voice owns the product; each discipline checks the others.
The Advisory Board.
Five scientists, five disciplines. Credentials below are held under written advisor agreements with consent for public attribution.
- Professor of Chemical & Environmental Engineering, Pusan National University
- Ph.D. in Materials Science, Seoul National University
- Postdoctoral research, Yale University & Georgia Tech
- Pioneered the hollow / yolk–shell mesoporous silica rod underlying Air Spicule™
- Published in JACS, Biomaterials Research, Materials Horizons
- Named inventor on the Air Spicule™ substance patent
- Senior Research Scientist, Seoul National University College of Medicine
- Ph.D. in Molecular Biology, KAIST
- Specialisation in senescent-cell pathways and NAD⁺ metabolism
- Published in Nature Aging, Cell Metabolism
- Advises EVORÍ’s senolytic formulation strategy and ingredient selection
- Associate Professor of Pharmacy, Ewha Womans University
- Ph.D. in Pharmaceutics, University of Michigan
- Expert in percutaneous absorption, barrier function, drug-delivery bioavailability
- Published in Int. J. Pharmaceutics, Pharmaceutical Research
- Lead advisor on Air Spicule™ penetration-depth optimisation
- Board-certified dermatologist, Samsung Medical Center
- Ph.D. in Dermatology, Seoul National University
- 10+ years in anti-aging treatment and adverse-event pharmacovigilance
- Lead clinical advisor on tolerability and adverse-event monitoring
- Protocol design for P&K clinical studies
- Professor of Pharmaceutical Policy & Law, Inha University
- Ph.D. in Regulatory Science, University of Southern California
- 15+ years in KFDA submissions, FDA compliance, international cosmetics regulation
- Counsel on claims substantiation and regulatory pathway
All advisor agreements include written consent for public attribution per industry standards. Attribution is published only after agreements are confirmed in writing.
The Research Ecosystem.
Behind the advisors stands a network of institutions that build, measure, and validate the platform.
- Nanomaterial R&D and structural characterisation (SEM / TEM at the Central Research Facilities). Origin of the mesoporous silica-rod technology.
- Spicule specialist since 2013. ODM manufacturer holding the Air Spicule™ patent estate; drives purification, impregnation, and silica-rod development.
- ODM manufacturing ecosystem; peer-reviewed research on topical NAD⁺ delivery informs EVORÍ’s longevity actives.
- Independent human application testing (n=23) — the institute behind EVORÍ’s clinical efficacy data.
The Air Spicule™ technology and its patent estate are held by EVORÍ's manufacturing partner. EVORÍ builds on this platform; it does not claim the underlying patents as its own.
How We Work Together.
Advice becomes accountability only when it is documented. Here is how the board's input reaches the product.